Cholinergic switching within neocortical inhibitory networks

Science

Volumn 281, Issue 5379, 1998, Pages 985-988

  Xiang, Zixiu ^a   Huguenard, John R ^a   Prince, David A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE RELEASE; ANIMAL CELL; ARTICLE; CHOLINERGIC NERVE; INTERNEURON; NEOCORTEX; NERVE CELL NETWORK; NONHUMAN; PRIORITY JOURNAL; VISUAL CORTEX;

ANIMALIA;

EID: 0032516707     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5379.985     Document Type: Article

References (56)

1. M. E. Hasselmo, Behav. Brain Res. 67, 1 (1995).
2. D. J. Stewart, D. F. MacFabe, L. W. Leung, Brain Res. 358, 404 (1985); J. C. Szerb, J. Physiol. 192, 329 (1967); D. A. McCormick and T. Bal, Annu. Rev. Neurosci. 20, 185 (1997); T. G. Aigner and M. Mishkin, Behav. Neural Biol. 45, 81 (1986); R. T. Bartus, R. L. Dean, B. Beer, A. S. Lippa, Science 217, 408 (1982); W. G. Sannita, in Perspective of Event-Related Potentials Research, G. Karmos et al., Eds. (Elsevier, Amsterdam, 1995), pp. 156-160; M. M. Mesulam, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 135-146.
3. D. J. Stewart, D. F. MacFabe, L. W. Leung, Brain Res. 358, 404 (1985); J. C. Szerb, J. Physiol. 192, 329 (1967); D. A. McCormick and T. Bal, Annu. Rev. Neurosci. 20, 185 (1997); T. G. Aigner and M. Mishkin, Behav. Neural Biol. 45, 81 (1986); R. T. Bartus, R. L. Dean, B. Beer, A. S. Lippa, Science 217, 408 (1982); W. G. Sannita, in Perspective of Event-Related Potentials Research, G. Karmos et al., Eds. (Elsevier, Amsterdam, 1995), pp. 156-160; M. M. Mesulam, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 135-146.
4. D. J. Stewart, D. F. MacFabe, L. W. Leung, Brain Res. 358, 404 (1985); J. C. Szerb, J. Physiol. 192, 329 (1967); D. A. McCormick and T. Bal, Annu. Rev. Neurosci. 20, 185 (1997); T. G. Aigner and M. Mishkin, Behav. Neural Biol. 45, 81 (1986); R. T. Bartus, R. L. Dean, B. Beer, A. S. Lippa, Science 217, 408 (1982); W. G. Sannita, in Perspective of Event-Related Potentials Research, G. Karmos et al., Eds. (Elsevier, Amsterdam, 1995), pp. 156-160; M. M. Mesulam, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 135-146.
5. D. J. Stewart, D. F. MacFabe, L. W. Leung, Brain Res. 358, 404 (1985); J. C. Szerb, J. Physiol. 192, 329 (1967); D. A. McCormick and T. Bal, Annu. Rev. Neurosci. 20, 185 (1997); T. G. Aigner and M. Mishkin, Behav. Neural Biol. 45, 81 (1986); R. T. Bartus, R. L. Dean, B. Beer, A. S. Lippa, Science 217, 408 (1982); W. G. Sannita, in Perspective of Event-Related Potentials Research, G. Karmos et al., Eds. (Elsevier, Amsterdam, 1995), pp. 156-160; M. M. Mesulam, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 135-146.
6. D. J. Stewart, D. F. MacFabe, L. W. Leung, Brain Res. 358, 404 (1985); J. C. Szerb, J. Physiol. 192, 329 (1967); D. A. McCormick and T. Bal, Annu. Rev. Neurosci. 20, 185 (1997); T. G. Aigner and M. Mishkin, Behav. Neural Biol. 45, 81 (1986); R. T. Bartus, R. L. Dean, B. Beer, A. S. Lippa, Science 217, 408 (1982); W. G. Sannita, in Perspective of Event-Related Potentials Research, G. Karmos et al., Eds. (Elsevier, Amsterdam, 1995), pp. 156-160; M. M. Mesulam, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 135-146.
7. D. J. Stewart, D. F. MacFabe, L. W. Leung, Brain Res. 358, 404 (1985); J. C. Szerb, J. Physiol. 192, 329 (1967); D. A. McCormick and T. Bal, Annu. Rev. Neurosci. 20, 185 (1997); T. G. Aigner and M. Mishkin, Behav. Neural Biol. 45, 81 (1986); R. T. Bartus, R. L. Dean, B. Beer, A. S. Lippa, Science 217, 408 (1982); W. G. Sannita, in Perspective of Event-Related Potentials Research, G. Karmos et al., Eds. (Elsevier, Amsterdam, 1995), pp. 156-160; M. M. Mesulam, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 135-146.
8. D. J. Stewart, D. F. MacFabe, L. W. Leung, Brain Res. 358, 404 (1985); J. C. Szerb, J. Physiol. 192, 329 (1967); D. A. McCormick and T. Bal, Annu. Rev. Neurosci. 20, 185 (1997); T. G. Aigner and M. Mishkin, Behav. Neural Biol. 45, 81 (1986); R. T. Bartus, R. L. Dean, B. Beer, A. S. Lippa, Science 217, 408 (1982); W. G. Sannita, in Perspective of Event-Related Potentials Research, G. Karmos et al., Eds. (Elsevier, Amsterdam, 1995), pp. 156-160; M. M. Mesulam, in Psychopharmacology: The Fourth Generation of Progress, F. E. Bloom and D. J. Kupfer, Eds. (Raven, New York, 1995), pp. 135-146.
9. J. T. Coyle, D. L. Price, M. R. DeLong, Science 219, 1184 (1983); P. Davies and A. J. Maloney, Lancet ii, 1403 (1976); M. Ruberg, A. Ploska, F. Javoy-Agid, Y. Agid, Brain Res. 232, 129 (1982).
10. J. T. Coyle, D. L. Price, M. R. DeLong, Science 219, 1184 (1983); P. Davies and A. J. Maloney, Lancet ii, 1403 (1976); M. Ruberg, A. Ploska, F. Javoy-Agid, Y. Agid, Brain Res. 232, 129 (1982).
11. J. T. Coyle, D. L. Price, M. R. DeLong, Science 219, 1184 (1983); P. Davies and A. J. Maloney, Lancet ii, 1403 (1976); M. Ruberg, A. Ploska, F. Javoy-Agid, Y. Agid, Brain Res. 232, 129 (1982).
12. F. Eckenstein and H. Thoenen, Neurosci. Lett. 36, 211 (1983); C. R. Houser, G. D. Crawford, R. P. Barber, P. M. Salvaterra, J. E. Vaughn, Brain Res. 266, 97 (1983); C. R. Houser, G. D. Crawford, P. M. Salvaterra, J. E. Vaughn, J. Comp. Neurol. 234, 17 (1985); C. B. Saper, ibid. 222, 313 (1984); C. C. Shute and P. R. Lewis, Brain 90, 497 (1967); B. H. Wainer et al., Brain Res. 308, 69 (1984); C. Beaulieu and P. Somogyi, J. Comp. Neurol. 304, 666 (1991).
13. F. Eckenstein and H. Thoenen, Neurosci. Lett. 36, 211 (1983); C. R. Houser, G. D. Crawford, R. P. Barber, P. M. Salvaterra, J. E. Vaughn, Brain Res. 266, 97 (1983); C. R. Houser, G. D. Crawford, P. M. Salvaterra, J. E. Vaughn, J. Comp. Neurol. 234, 17 (1985); C. B. Saper, ibid. 222, 313 (1984); C. C. Shute and P. R. Lewis, Brain 90, 497 (1967); B. H. Wainer et al., Brain Res. 308, 69 (1984); C. Beaulieu and P. Somogyi, J. Comp. Neurol. 304, 666 (1991).
14. F. Eckenstein and H. Thoenen, Neurosci. Lett. 36, 211 (1983); C. R. Houser, G. D. Crawford, R. P. Barber, P. M. Salvaterra, J. E. Vaughn, Brain Res. 266, 97 (1983); C. R. Houser, G. D. Crawford, P. M. Salvaterra, J. E. Vaughn, J. Comp. Neurol. 234, 17 (1985); C. B. Saper, ibid. 222, 313 (1984); C. C. Shute and P. R. Lewis, Brain 90, 497 (1967); B. H. Wainer et al., Brain Res. 308, 69 (1984); C. Beaulieu and P. Somogyi, J. Comp. Neurol. 304, 666 (1991).
15. F. Eckenstein and H. Thoenen, Neurosci. Lett. 36, 211 (1983); C. R. Houser, G. D. Crawford, R. P. Barber, P. M. Salvaterra, J. E. Vaughn, Brain Res. 266, 97 (1983); C. R. Houser, G. D. Crawford, P. M. Salvaterra, J. E. Vaughn, J. Comp. Neurol. 234, 17 (1985); C. B. Saper, ibid. 222, 313 (1984); C. C. Shute and P. R. Lewis, Brain 90, 497 (1967); B. H. Wainer et al., Brain Res. 308, 69 (1984); C. Beaulieu and P. Somogyi, J. Comp. Neurol. 304, 666 (1991).
16. F. Eckenstein and H. Thoenen, Neurosci. Lett. 36, 211 (1983); C. R. Houser, G. D. Crawford, R. P. Barber, P. M. Salvaterra, J. E. Vaughn, Brain Res. 266, 97 (1983); C. R. Houser, G. D. Crawford, P. M. Salvaterra, J. E. Vaughn, J. Comp. Neurol. 234, 17 (1985); C. B. Saper, ibid. 222, 313 (1984); C. C. Shute and P. R. Lewis, Brain 90, 497 (1967); B. H. Wainer et al., Brain Res. 308, 69 (1984); C. Beaulieu and P. Somogyi, J. Comp. Neurol. 304, 666 (1991).
17. F. Eckenstein and H. Thoenen, Neurosci. Lett. 36, 211 (1983); C. R. Houser, G. D. Crawford, R. P. Barber, P. M. Salvaterra, J. E. Vaughn, Brain Res. 266, 97 (1983); C. R. Houser, G. D. Crawford, P. M. Salvaterra, J. E. Vaughn, J. Comp. Neurol. 234, 17 (1985); C. B. Saper, ibid. 222, 313 (1984); C. C. Shute and P. R. Lewis, Brain 90, 497 (1967); B. H. Wainer et al., Brain Res. 308, 69 (1984); C. Beaulieu and P. Somogyi, J. Comp. Neurol. 304, 666 (1991).
18. F. Eckenstein and H. Thoenen, Neurosci. Lett. 36, 211 (1983); C. R. Houser, G. D. Crawford, R. P. Barber, P. M. Salvaterra, J. E. Vaughn, Brain Res. 266, 97 (1983); C. R. Houser, G. D. Crawford, P. M. Salvaterra, J. E. Vaughn, J. Comp. Neurol. 234, 17 (1985); C. B. Saper, ibid. 222, 313 (1984); C. C. Shute and P. R. Lewis, Brain 90, 497 (1967); B. H. Wainer et al., Brain Res. 308, 69 (1984); C. Beaulieu and P. Somogyi, J. Comp. Neurol. 304, 666 (1991).
19. Y. Kawaguchi, C. J. Wilson, S. J. Augood, P. C. Emson, Trends. Neurosci. 18, 527 (1995); C. R. Houser, S. H. Hendry, E. G. Jones, J. E. Vaughn, J. Neurocytol. 12, 617 (1983); P. Somogyi et al., J. Neurosci. 4, 2590 (1984); S. H. Hendry et al., Exp. Brain Res. 76, 467 (1989).
20. Y. Kawaguchi, C. J. Wilson, S. J. Augood, P. C. Emson, Trends. Neurosci. 18, 527 (1995); C. R. Houser, S. H. Hendry, E. G. Jones, J. E. Vaughn, J. Neurocytol. 12, 617 (1983); P. Somogyi et al., J. Neurosci. 4, 2590 (1984); S. H. Hendry et al., Exp. Brain Res. 76, 467 (1989).
21. Y. Kawaguchi, C. J. Wilson, S. J. Augood, P. C. Emson, Trends. Neurosci. 18, 527 (1995); C. R. Houser, S. H. Hendry, E. G. Jones, J. E. Vaughn, J. Neurocytol. 12, 617 (1983); P. Somogyi et al., J. Neurosci. 4, 2590 (1984); S. H. Hendry et al., Exp. Brain Res. 76, 467 (1989).
22. Y. Kawaguchi, C. J. Wilson, S. J. Augood, P. C. Emson, Trends. Neurosci. 18, 527 (1995); C. R. Houser, S. H. Hendry, E. G. Jones, J. E. Vaughn, J. Neurocytol. 12, 617 (1983); P. Somogyi et al., J. Neurosci. 4, 2590 (1984); S. H. Hendry et al., Exp. Brain Res. 76, 467 (1989).
23. A. M. Thomson, D. C. West, J. Hahn, J. Deuchars, J. Physiol. 496, 81 (1996).
24. B. E. Jones and S. H. Hendry, in Cerebral Cortex, A. Peters and E. G. Jones, Eds. (Plenum, New York, 1984), pp. 309-336.
25. Y. Kawaguchi, J. Neurophysiol. 69, 416 (1993); Y. Kawaguchi and Y. Kubota, ibid. 70, 387 (1993).
26. Y. Kawaguchi, J. Neurophysiol. 69, 416 (1993); Y. Kawaguchi and Y. Kubota, ibid. 70, 387 (1993).
27. s was compensated about 50 to 75 %.
28. About 20 to 50 pl of 5 mM ACh was applied by pressure pulses (25 to 40 kPa for 25 to 200 ms) through a "puffer" pipette (2 to 4 μm in tip diameter) placed 40 to 60 μm away from the recorded cell. Muscarinic and nicotinic receptor antagonists, scopolamine (5 mM) and hexamethonium (5 mM), were applied in 30 to 50 μl of ACSF directly into the recording chamber while it was perfused with ACSF at the rate of 1.5 ml/min. Effects of these antagonists usually appeared within 1 to 4 min. Other agents such as 6,7-dinitroquinoxoline-2,3-dione (DNQX, 20 μM) and 3-(2-carboxypiperazin-4-yl)-1-propenyl-1-phosphonic acid (D-CPPene, 5 μM), GABA receptor antagonist, and bicuculline (10 μM), as well as tetrodotoxin (TTX, 1 μM), were added to the perfusate and bath applied. To estimate the reversal potential of ACh-induced conductance changes, we plotted the current responses versus ramp voltage in control solution and after drug application and obtained current difference - voltage (Δ/-V) plots by subtracting the control current from ACh current. We estimated the reversal potentials by extrapolating the linear fitting curve to Δ/ = 0 or using the crossing points of the Δ/-V curve to the voltage axis at Δ/ = 0 (Fig. 3).
29. After the physiological experiments, slices containing biocytin-filled neurons were processed with standard avidin-biotin-peroxidase methods as described elsewhere in detail [K. Horikawa and W. E. Armstrong, J. Neurosci. Methods 25, 1 (1988); G. F. Tseng, I. Parada, D. A. Prince, ibid. 37, 121 (1991)]. Labeled neurons were examined under the light microscope and drawn with a camera lucida, and the axonal arbor representations were exported as bitmap files. Total axonal length per 50-μm horizontal strip was estimated by measuring the integrated bitmap density. Data were then aligned approximately to the middle of the layer V for statistical analysis for which the Mann-Whitney test was used. The results were presented as mean ± SEM.
30. After the physiological experiments, slices containing biocytin-filled neurons were processed with standard avidin-biotin-peroxidase methods as described elsewhere in detail [K. Horikawa and W. E. Armstrong, J. Neurosci. Methods 25, 1 (1988); G. F. Tseng, I. Parada, D. A. Prince, ibid. 37, 121 (1991)]. Labeled neurons were examined under the light microscope and drawn with a camera lucida, and the axonal arbor representations were exported as bitmap files. Total axonal length per 50-μm horizontal strip was estimated by measuring the integrated bitmap density. Data were then aligned approximately to the middle of the layer V for statistical analysis for which the Mann-Whitney test was used. The results were presented as mean ± SEM.
31. R. C. Foehring, N. M. Lorenzon, P. Herron, C. J. Wilson, J. Neurophysiol. 66, 1825 (1991).
32. D. A. McCormick, B. W. Connors, J. W. Lighthall, D. A. Prince, ibid. 54, 782 (1985).
33. A receptor antagonist, bicuculline (10 μM) [n = 2 for LTS cells and n = 2 for FS cells; Fig. 2, C (bottom) and D (bottom)]; or 1 μM TTX (n = 3 for LTS and n = 2 for FS; Z. Xiang, J. R. Huguenard, D. A. Prince, data not shown).
34. A. U. Larkman, G. Major, K. J. Stratford, J. J. Jack, J. Comp. Neurol. 323, 137 (1992); N. Spruston, D. B. Jaffe, D. Johnston, Trends. Neurosci. 17, 161 (1994).
35. A. U. Larkman, G. Major, K. J. Stratford, J. J. Jack, J. Comp. Neurol. 323, 137 (1992); N. Spruston, D. B. Jaffe, D. Johnston, Trends. Neurosci. 17, 161 (1994).
36. Z. Xiang, I. Parada, J. R. Huguenard, D. A. Prince, Soc. Neurosci. Abstr. 23, 359 (1997).
37. - channels [J. L. Barker and N. L. Harrison, J. Physiol. 403, 41 (1988)]. In such a recording condition, sIPSCs were inward currents at a holding potential of -70 mV. ACh were locally applied as described in (10). Kolmogorov-Smirnov (K-S) statistics were used to analyze the sIPSC data.
38. In one pyramidal cell, ACh application gave rise to an increase in frequency of large, slow events. This cell showed an increase in sIPSC rise time after ACh application similar to that seen in six other neurons. We speculate that the large-amplitude sIPSCs in this particular case may have reflected an unusually large number of synaptic contacts from one or more LTS cells onto the pyramidal neuron.
39. D. A. McCormick and D. A. Prince, J. Neurosci. 7, 742 (1987); L. J. Reece and P. A. Schwartzkroin, Brain Res. 540, 287 (1991); A. R. McQuiston and D. V. Madison, Soc. Neurosci. Abstr. 23, 2009 (1997); C. J. Frazier et al., J. Neurosci. 18, 1187 (1998); M. Alkondon, E. F. Pereira, C. T. Barbosa, E. X. Albuquerque, J. Pharmacol. Exp. Ther. 283, 1396 (1997).
40. D. A. McCormick and D. A. Prince, J. Neurosci. 7, 742 (1987); L. J. Reece and P. A. Schwartzkroin, Brain Res. 540, 287 (1991); A. R. McQuiston and D. V. Madison, Soc. Neurosci. Abstr. 23, 2009 (1997); C. J. Frazier et al., J. Neurosci. 18, 1187 (1998); M. Alkondon, E. F. Pereira, C. T. Barbosa, E. X. Albuquerque, J. Pharmacol. Exp. Ther. 283, 1396 (1997).
41. D. A. McCormick and D. A. Prince, J. Neurosci. 7, 742 (1987); L. J. Reece and P. A. Schwartzkroin, Brain Res. 540, 287 (1991); A. R. McQuiston and D. V. Madison, Soc. Neurosci. Abstr. 23, 2009 (1997); C. J. Frazier et al., J. Neurosci. 18, 1187 (1998); M. Alkondon, E. F. Pereira, C. T. Barbosa, E. X. Albuquerque, J. Pharmacol. Exp. Ther. 283, 1396 (1997).
42. D. A. McCormick and D. A. Prince, J. Neurosci. 7, 742 (1987); L. J. Reece and P. A. Schwartzkroin, Brain Res. 540, 287 (1991); A. R. McQuiston and D. V. Madison, Soc. Neurosci. Abstr. 23, 2009 (1997); C. J. Frazier et al., J. Neurosci. 18, 1187 (1998); M. Alkondon, E. F. Pereira, C. T. Barbosa, E. X. Albuquerque, J. Pharmacol. Exp. Ther. 283, 1396 (1997).
43. D. A. McCormick and D. A. Prince, J. Neurosci. 7, 742 (1987); L. J. Reece and P. A. Schwartzkroin, Brain Res. 540, 287 (1991); A. R. McQuiston and D. V. Madison, Soc. Neurosci. Abstr. 23, 2009 (1997); C. J. Frazier et al., J. Neurosci. 18, 1187 (1998); M. Alkondon, E. F. Pereira, C. T. Barbosa, E. X. Albuquerque, J. Pharmacol. Exp. Ther. 283, 1396 (1997).
44. K. H. Lee and D. A. McCormick, J. Neurophysiol. 73, 2123 (1995).
45. A. R. McQuiston and D. V. Madison, Soc. Neurosci. Abstr. 22, 786 (1996).
46. D. A. McCormick and D. A. Prince, Nature 319, 402 (1986); D. A. McCormick and H. C. Pape, ibid. 334, 246 (1988).
47. D. A. McCormick and D. A. Prince, Nature 319, 402 (1986); D. A. McCormick and H. C. Pape, ibid. 334, 246 (1988).
48. D. A. McCormick and D. A. Prince, Proc. Natl. Acad. Sci. U.S.A. 82, 6344 (1985).
49. _, J. Physiol. 375, 169 (1986).
50. Y. Kawaguchi, J. Neurophysiol. 78, 1743 (1997).
51. L. J. Reece and P. A. Schwartzkroin, Brain Res. 566, 115 (1991); T. A. Pitler and B. E. Alger, J. Physiol. 450, 127 (1992).
52. L. J. Reece and P. A. Schwartzkroin, Brain Res. 566, 115 (1991); T. A. Pitler and B. E. Alger, J. Physiol. 450, 127 (1992).
53. J. W. Phillis and D. H. York, Brain Res. 10, 297 (1968); K. Krnjevic, Physiol. Rev. 54, 418 (1974).
54. J. W. Phillis and D. H. York, Brain Res. 10, 297 (1968); K. Krnjevic, Physiol. Rev. 54, 418 (1974).
55. D. A. Prince and B. J. Wilder, Arch. Neurol. 16, 194 (1967).
56. We thank I. Parada for her excellent assistance during the course of the experiments. The work was supported by NIH grants NS 12151, NS 07280, NS 06477, and NS 10474 from the National Institute of Neurological Disorders and Stroke and the Morris and Pimley research funds.